InsidersTradesSigma
Track the IRADIMED CORPORATION stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €1.1bn. The latest transaction was reported on 3 September 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: Monty K. Allen. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
IRADIMED CORPORATION es una empresa centrada en el desarrollo de tecnologías médicas innovadoras, en particular sistemas de monitorización de pacientes. Cotiza en NASDAQ con el símbolo IRMD.